Differential regulation of proinflammatory mediators following LPS- and ATP-induced activation of monocytes from patients with antiphospholipid syndrome

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Martirosyan, Anush ^a,b   Petrek, Martin ^a   Navratilova, Zdenka ^a   Blbulyan, Armen ^c   Boyajyan, Anna ^b   Manukyan, Gayane ^a,b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^c Department of Obstetrics Institute of Perinatology Obstetrics and Gynecology   (Armenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; CCL2 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; STAT3 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CELL STIMULATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MONOCYTE; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CASE CONTROL STUDY; DRUG EFFECTS; GENETIC SUSCEPTIBILITY; INFLAMMATION; METABOLISM;

ADENOSINE TRIPHOSPHATE; ADULT; ANTICIPATION, GENETIC; ANTIPHOSPHOLIPID SYNDROME; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CXCL10; FEMALE; HUMANS; INFLAMMATION; INTERLEUKINS; LIPOPOLYSACCHARIDES; MONOCYTES; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 2;

EID: 84924301462     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/292851     Document Type: Article

References (50)

1. G. R. de Jesus, N. Agmon-Levin, C. A. Andrade et al., "14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome," Autoimmunity Reviews, vol. 13, no. 8, pp. 795-813, 2014.
2. J. C. Gris and S. Bouvier, "Antiphospholipid syndrome: looking for a refocusing," Thrombosis Research, vol. 131, supplement 1, pp. S28-S31, 2013.
3. E. Raschi, C. Testoni, D. Bosisio et al., "Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies," Blood, vol. 101, no. 9, pp. 3495-3500, 2003.
4. J. Zhang, S. Fu, S. Sun, Z. Li, and B. Guo, "Inflammasome activation has an important role in the development of spontaneous colitis," Mucosal Immunology, vol. 7, no. 5, pp. 1139-1150, 2014.
5. V. Kumar, S. R. Ali, S. Konrad et al., "Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice,"The Journal of Clinical Investigation, vol. 116, no. 2, pp. 512-520, 2006.
6. C. López-Pedrera, P. Buendía, M. J. Cuadrado et al., "Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-B/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway," Arthritis & Rheumatism, vol. 54, no. 1, pp. 301-311, 2006.
7. D. Ware Branch and G. M. Rodgers, "Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis," The American Journal of Obstetrics and Gynecology, vol. 168, no. 1, pp. 206-210, 1993.
8. J.-C. Reverter, D. Tàssies, J. Font et al., "Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes," Arthritis & Rheumatism, vol. 41, no. 8, pp. 1420-1427, 1998.
9. A. Kornberg, M. Blank, S. Kaufman, and Y. Shoenfeld, "Induction of tissue factor-like activity in monocytes by anticardiolipin antibodies," Journal of Immunology, vol. 153, no. 3, pp. 1328-1332, 1994.
10. M. J. Cuadrado, C. López-Pedrera, M. A. Khamashta et al., "Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression," Arthritis and Rheumatism, vol. 40, no. 5, pp. 834-841, 1997.
11. O. Amengual, T. Atsumi, M. A. Khamashta, and G. R. V. Hughes, "The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome," Thrombosis and Haemostasis, vol. 79, no. 2, pp. 276-281, 1998.
12. R.R.Forastiero,M. E.Martinuzzo, andG.F.DeLarrañaga, "Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies," Lupus, vol. 14, no. 2, pp. 129-136, 2005.
13. M. Kuwana, "Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity," Thrombosis Research, vol. 114, no. 5-6, pp. 347-355, 2004.
14. W. Solbach, H.Moll, and M. Röllinghoff, "Lymphocytes play the music but the macrophage calls the tune," Immunology Today, vol. 12, no. 1, pp. 4-6, 1991.
15. N. V. Serbina, T. Jia, T. M. Hohl, and E. G. Pamer, "Monocytemediated defense against microbial pathogens," Annual Review of Immunology, vol. 26, pp. 421-452, 2008.
16. O. Takeuchi and S. Akira, "Pattern recognition receptors and inflammation," Cell, vol. 140, no. 6, pp. 805-820, 2010.
17. C. A. Janeway Jr. and R. Medzhitov, "Innate immune recognition," Annual Review of Immunology, vol. 20, pp. 197-216, 2002.
18. C. A. Dinarello, "Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist," International Reviews of Immunology, vol. 16, no. 5-6, pp. 457-499, 1998.
19. A. Rubartelli, F. Cozzolino, M. Talio, and R. Sitia, "A novel secretory pathway for interleukin-1, a protein lacking a signal sequence," EMBO Journal, vol. 9, no. 5, pp. 1503-1510, 1990.
20. R. J. Griffiths, E. J. Stam, J. T. Downs, and I. G. Otterness, "ATP induces the release of IL-1 from LPS-primed cells in vivo," Journal of Immunology, vol. 154, no. 6, pp. 2821-2828, 1995.
21. R. E. Laliberte, D. G. Perregaux, P. McNiff, and C. A. Gabel, "Human monocyte ATP-induced IL-1 posttranslational processing is a dynamic process dependent on in vitro growth conditions," Journal of Leukocyte Biology, vol. 62, no. 2, pp. 227-239, 1997.
22. F. Martinon and J. Tschopp, "Inflammatory caspases and inflammasomes: master switches of inflammation," Cell Death & Differentiation, vol. 14, no. 1, pp. 10-22, 2007.
23. F. Martinon, A. Mayor, and J. Tschopp, "The inflammasomes: guardians of the body," Annual Review of Immunology, vol. 27, pp. 229-265, 2009.
24. C. B. Levandowski, C. M.Mailloux, T. M. Ferrara et al., "NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1 processing via the NLRP1 inflammasome," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 8, pp. 2952-2956, 2013.
25. P. R. J. Ames, I. Antinolfi, A. Ciampa et al., "Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease?" Rheumatology, vol. 47, no. 12, pp. 1832-1837, 2008.
26. L. M. Wahl, S. M. Wahl, L. E. Smythies, and P. D. Smith, "Isolation of humanmonocyte populations," in Current Protocols in Immunology, chapter 7:unit 7.6A, 2006.
27. A. M. Ercolini and S. D. Miller, "The role of infections in autoimmune disease," Clinical and Experimental Immunology, vol. 155, no. 1, pp. 1-15, 2009.
28. R. Cervera, R. A. Asherson, M. L. Acevedo et al., "Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients," Annals of the Rheumatic Diseases, vol. 63, no. 10, pp. 1312-1317, 2004.
29. P. Sfriso, A. Ghirardello, C. Botsios et al., "Infections and autoimmunity: themultifaceted relationship," Journal of Leukocyte Biology, vol. 87, no. 3, pp. 385-395, 2010.
30. A. Iwasaki and R.Medzhitov, "Regulation of adaptive immunity by the innate immune system," Science, vol. 327, no. 5963, pp. 291-295, 2010.
31. K. Hoebe, E. Janssen, and B. Beutler, "The interface between innate and adaptive immunity," Nature Immunology, vol. 5, no. 10, pp. 971-974, 2004.
32. L. B. Nicholson, B. J. E. Raveney, and M. Munder, "Monocyte dependent regulation of autoimmune inflammation," Current Molecular Medicine, vol. 9, no. 1, pp. 23-29, 2009.
33. E. A. Fox and S. R. Kahn, "The relationship between inflammation and venous thrombosis. A systematic review of clinical studies," Thrombosis and Haemostasis, vol. 94, no. 2, pp. 362-365, 2005.
34. E. Shantsila and G. Y. H. Lip, "The role of monocytes in thrombotic disorders: insights from tissue factor, monocyteplatelet aggregates and novel mechanisms," Thrombosis and Haemostasis, vol. 102, no. 5, pp. 916-924, 2009.
35. M.-L. von Brühl, K. Stark, A. Steinhart et al., "Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo,"The Journal of Experimental Medicine, vol. 209, no. 4, pp. 819-835, 2012.
36. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, "IL-17 and Th17 cells," Annual Review of Immunology, vol. 27,no. 1, pp.485-517, 2009.
37. H. G. Evans, N. J. Gullick, S. Kelly et al., "In vivo activated monocytes fromthe site of inflammation in humans specifically promoteTh17 responses," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 15, pp. 6232-6237, 2009.
38. B.Afzali, G. Lombardi, R. I. Lechler, and G. M. Lord, "The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease," Clinical and Experimental Immunology, vol. 148, no. 1, pp. 32-46, 2007.
39. D. Perregaux and C. A. Gabel, "Interleukin-1beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity,"The Journal of Biological Chemistry, vol. 269, no. 21, pp. 15195-15203, 1994.
40. P. Bodin and G. Burnstock, "Increased release of ATP from endothelial cells during acute inflammation," Inflammation Research, vol. 47, no. 8, pp. 351-354, 1998.
41. S. Mariathasan, D. S. Weiss, K. Newton et al., "Cryopyrin activates the inflammasome in response to toxins and ATP," Nature, vol. 440, no. 7081, pp. 228-232, 2006.
42. M. J. L. Bours, E. L. R. Swennen, F. di Virgilio, B. N. Cronstein, and P. C. Dagnelie, "Adenosine 5triphosphate and adenosine as endogenous signalingmolecules in immunity and inflammation," Pharmacology and Therapeutics, vol. 112, no. 2, pp. 358-404, 2006.
43. R. Rizzo, D. Ferrari, L. Melchiorri et al., "Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G fromhumanmonocytes," Journal of Immunology, vol. 183, no. 7, pp. 4302-4311, 2009.
44. E. L. R. Swennen, A. Bast, and P. C. Dagnelie, "Immunoregulatory effects of adenosine 5triphosphate on cytokine release from stimulated whole blood," European Journal of Immunology, vol. 35, no. 3, pp. 852-858, 2005.
45. M. J. Leo Bours, P. C. Dagnelie, A. L. Giuliani, A. Wesselius, and F. Di Virgilio, "P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation," Frontiers in Bioscience-Scholar, vol. 3, no. 4, pp. 1443-1456, 2011.
46. Y. Qu, L. Franchi, G. Nunez, and G. R. Dubyak, "Nonclassical IL-1 secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages," Journal of Immunology, vol. 179, no. 3, pp. 1913-1925, 2007.
47. A. La Sala, D. Ferrari, F. Di Virgilio, M. Idzko, J. Norgauer, and G. Girolomoni, "Alerting and tuning the immune response by extracellular nucleotides," Journal of Leukocyte Biology, vol. 73, no. 3, pp. 339-343, 2003.
48. R. De Waal Malefyt, J. Haanen, H. Spits et al., "Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression," The Journal of Experimental Medicine, vol. 174, no. 4, pp. 915-924, 1991.
49. L.Williams, G. Jarai, A. Smith, and P. Finan, "IL-10 expression profiling in human monocytes," Journal of Leukocyte Biology, vol. 72, no. 4, pp. 800-809, 2002.
50. J. Zhang and K. R. McCrae, "Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-2 glycoprotein I antibodies," Blood, vol. 105, no. 5, pp. 1964-1969, 2005.